SourceOne Launches Cholesstrinol Platform

CHICAGO— SourceOne™ Global Partners developed an ingredient platform, Cholesstrinol™, to competitively brand position the combination of its proprietary heart-health formulas. The combination of TocoSource® Palm Tocotrienols and PMFsource™ Citrus Bioflavonoids, as found in Sytrinol®, forms the foundation of the ingredient platform, which Jesse Lopez, president and CEO, SourceOne, noted also includes high-potency omega-3 (OmegaSmart™), phytosterols (SterolSource®), coenzyme Q10 (CoQsource™) and gamma-tocopherol.

Lopez said each of the ingredients under the Cholesstrinol umbrella is supported by strong clinical evidence demonstrating the ability to support various aspects of cardiovascular health. Effects include improving cholesterol and triglyceride levels, providing antioxidant effects, promoting the body’s anti-inflammatory response and supporting healthy blood pressure levels.

The brand story and supportive marketing message with clinical support should make an easy-to-understand package for consumers, Lopez said. “We anticipate tremendous positive consumer response as there is no need for laborious guesswork or research on their part,” he added. “The Cholesstrinol formulas available today have one important thing in common: less is more. By effectively using all the members of the family and highlighting their synergistic capacities in the field of heart health, the message is clear: you need less to achieve more. Fewer soft gels in your daily regimen to achieve better results, and less active in a beverage formula because of the optimization of the efficacy of the individual components are examples of the brand message.”